Physician profile
Robert Oneil Gingery
NPI 1417974460
$2,768.42
in general payments reported to CMS, 2019-2025
12 companies · $169 in 2025
The $169 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $852 · 2020: $268 · 2021: $275 · 2022: $304 · 2023: $589 · 2024: $313 · 2025: $169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,071.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,070.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,006.87 | 2021-2025 | Endurant Iis, In.Pact Admiral, Venaseal |
| Medtronic Vascular, INC. | $497.19 | 2019-2020 | |
| Lemaitre Vascular, INC. | $336.41 | 2019-2023 | Artegraft Vascular Graft, Syntel Embolectomy Catheter (Spring Tip) |
| Boston Scientific Corporation | $248.09 | 2019-2022 | |
| Penumbra, INC. | $243.02 | 2020-2023 | Penumbra System |
| Mallinckrodt Enterprises LLC | $110.85 | 2019 | |
| Smith+Nephew, INC. | $88.74 | 2019-2022 | |
| Organogenesis INC. | $80.60 | 2022 | |
| Abbott Laboratories | $68.08 | 2019-2020 | |
| Tactile Systems Technology INC | $43.81 | 2022-2024 | Entre Plus, Flexitouch Plus |
| Biocompatibles, INC. | $24.61 | 2019 | |
| Mimedx Group, INC. | $20.15 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Gingery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.